Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

An effective cas13a-based anti-dengue virus nucleic acid target and its application

A dengue virus and target technology, which is applied in the field of nucleic acid targets against dengue virus, can solve the problems of inability to target and clear RNA viruses, and achieve the effects of less drug resistance, high efficiency, and strong specificity

Active Publication Date: 2021-08-31
ACADEMY OF MILITARY MEDICAL SCI +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the field of anti-virus, researchers have successfully used CRISPR-Cas9 technology to achieve precise targeting and high-efficiency inhibition of DNA viruses such as HPV and HBV. However, the CRISPR-Cas9 system can only achieve DNA editing and DNA virus targeting. Clearance, it is not yet possible to directly target and clear RNA viruses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An effective cas13a-based anti-dengue virus nucleic acid target and its application
  • An effective cas13a-based anti-dengue virus nucleic acid target and its application
  • An effective cas13a-based anti-dengue virus nucleic acid target and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1. Preparation and screening of CRISPR-Cas13a target sequence targeting dengue virus

[0037] 1. Design and synthesis of crRNA sequence targeting dengue virus DENV-2

[0038] Taking the genome sequence (Genebank ID: U87411) of type 2 dengue virus DENV-2 (strain 16681) as the reference sequence, for the 6 genes (PrM, NS2a, NS2b, NS3, NS4a, 3'UTR) of type 2 dengue virus, A continuous 29 nucleotide sequence was selected in each gene sequence as the target sequence of the CRISPR-Cas13a system.

[0039] The selected 6 target sequences were respectively reverse-complemented to obtain 6 reverse-complementary strands;

[0040] Then add GGGGATTTAGACTACCCCAAAAACGAAGGGGACTAAAAC to the 5' end of the sequence of the 6 reverse complementary strands to synthesize the forward oligonucleotide sequence (Table 1);

[0041] Using the forward oligonucleotide sequence as a template, use T7-crRNA-F: TAATACGACTCACTATAGGGGATTTAGACTACCCCAA as an upstream primer, and use R-NNN (Table 1:...

Embodiment 2

[0076] Example 2. Efficiency of CRISPR-Cas13a system targeting crRNA-NS3 inhibiting dengue virus replication and expression in vitro

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses an effective Cas13a-based anti-dengue virus nucleic acid target and application thereof. The present invention provides a CRISPR-Cas13a system for inhibiting dengue virus, comprising Cas13a protein and crRNA corresponding to the NS3 gene target of dengue virus, or a complex formed by the two; the NS3 gene target of dengue virus It is the 4657-4685th position of the NS3 gene nucleotide sequence of dengue virus. The present invention discovers a new anti-dengue virus method, which is different from traditional anti-virus methods, directly targeting viral nucleic acid, specifically degrading target genes, and making the virus lose its ability to replicate. Therefore, it has the characteristics of high efficiency, strong specificity, and programmable, and it is not easy to produce drug resistance caused by traditional antiviral drugs. It may become a new antiviral drug in the future.

Description

technical field [0001] The invention belongs to the technical field of gene mutation and genetic engineering, and relates to an effective Cas13a-based anti-dengue virus nucleic acid target and application thereof. Background technique [0002] With global warming and increasing population mobility, dengue fever is increasingly becoming an important infectious disease in tropical and subtropical regions. Dengue virus is the pathogen of dengue fever and is divided into four serotypes, named DENV-1 and DENV-2 respectively. , DENV-3 and DENV-4. About 50 million to 100 million people are infected with dengue virus every year, and about 1% of the infected people develop into severe patients who need hospitalization, manifest as dengue hemorrhagic fever and dengue shock syndrome, and even die. The dependent virus infection enhancement (antibody-dependent enhancement, ADE) has led to difficulties in the development of dengue virus vaccines, and there is no specific therapeutic drug...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/113C12N9/22A61K31/7088A61K39/12A61P31/14
CPCA61K31/7088A61K39/12A61P31/14C12N9/22C12N15/1131C12N2310/10C12N2770/24134Y02A50/30
Inventor 寇志华李浩宋宏彬周育森李军锋王珊董雪郭彦谢靖贾雷立刘鸿博邱少富杨超杰
Owner ACADEMY OF MILITARY MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com